KLRS

Kalaris Therapeutics, Inc. Common Stock
KLRS

Overview Fund Activity

84 hedge funds and large institutions have $110M invested in Kalaris Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 23 reducing their positions, and 12 closing their positions.

Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
31
Reduced
23
Closed
12
Calls
$129K
Puts
–
Net Calls
+$129K
Net Calls Change
+$129K

Top Buyers

1
Alkeon Capital Management
1
Alkeon Capital Management
New York
$10.7M
2
GC
2
GMT Capital
Georgia
$7.38M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.18M
4
BlackRock
4
BlackRock
New York
$9.67M
5
State Street
5
State Street
Massachusetts
$2.81M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$28M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$7.99M
4
Federated Hermes
4
Federated Hermes
Pennsylvania
$1K
5
Citadel Advisors
5
Citadel Advisors
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$28M 7,187,884 -748,646 -9%
Alkeon Capital Management
2
Alkeon Capital Management
New York
$10.7M 2,753,909 +2,000,000 +265%
BlackRock
3
BlackRock
New York
$9.67M 2,478,605 +247,686 +11%
AG
4
Artal Group
Luxembourg
$9.06M 2,323,371 – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.99M 2,048,010 -630,291 -24%
GC
6
GMT Capital
Georgia
$7.38M 1,891,170 +753,100 +66%
AIG
7
American International Group
New York
$4.46M 1,143,425 -107 -0%
WP
8
Woodline Partners
California
$4.24M 1,087,093 – –
RG
9
Redmile Group
California
$3.21M 823,371 – –
Massachusetts Financial Services
10
Massachusetts Financial Services
Massachusetts
$3.04M 779,168 -5,852 -0.7%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$3.03M 775,807 +11,899 +2%
State Street
12
State Street
Massachusetts
$2.81M 720,201 +145,022 +25%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$2.15M 551,055 +1,024 +0.2%
Marshall Wace
14
Marshall Wace
United Kingdom
$1.27M 324,658 – –
Renaissance Technologies
15
Renaissance Technologies
New York
$1.18M 301,701 +248,601 +468%
Northern Trust
16
Northern Trust
Illinois
$1.09M 279,551 -4,952 -2%
State of Wisconsin Investment Board
17
State of Wisconsin Investment Board
Wisconsin
$923K 236,577 +142,777 +152%
Goldman Sachs
18
Goldman Sachs
New York
$892K 228,667 +120,563 +112%
Charles Schwab
19
Charles Schwab
California
$851K 218,134 +13,010 +6%
Nuveen Asset Management
20
Nuveen Asset Management
Illinois
$694K 178,060 +97,246 +120%
Morgan Stanley
21
Morgan Stanley
New York
$551K 141,217 +49,154 +53%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$364K 93,144 +5,057 +6%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$356K 91,112 +20,725 +29%
SB
24
Samsara BioCapital
California
$321K 82,336 – –
Lido Advisors
25
Lido Advisors
California
$309K 79,416 – –
1
2 3 4